| 000 | 01811 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514045550.0 | ||
| 264 | 0 | _c20021118 | |
| 008 | 200211s 0 0 eng d | ||
| 022 | _a1073-449X | ||
| 024 | 7 |
_a10.1164/rccm.2108091 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSharma, Surendra K | |
| 245 | 0 | 0 |
_aEvaluation of clinical and immunogenetic risk factors for the development of hepatotoxicity during antituberculosis treatment. _h[electronic resource] |
| 260 |
_bAmerican journal of respiratory and critical care medicine _cOct 2002 |
||
| 300 |
_a916-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 |
_aAntitubercular Agents _xadverse effects |
| 650 | 0 | 4 |
_aChemical and Drug Induced Liver Injury _xepidemiology |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 |
_aHLA-DQ Antigens _xgenetics |
| 650 | 0 | 4 |
_aHLA-DR Antigens _xgenetics |
| 650 | 0 | 4 | _aHaplotypes |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunogenetics |
| 650 | 0 | 4 |
_aIndia _xepidemiology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aMultivariate Analysis |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSerum Albumin _xmetabolism |
| 650 | 0 | 4 |
_aTuberculosis, Pulmonary _xcomplications |
| 700 | 1 | _aBalamurugan, Arumugam | |
| 700 | 1 | _aSaha, Pradip Kumar | |
| 700 | 1 | _aPandey, Ravindra M | |
| 700 | 1 | _aMehra, Narinder K | |
| 773 | 0 |
_tAmerican journal of respiratory and critical care medicine _gvol. 166 _gno. 7 _gp. 916-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1164/rccm.2108091 _zAvailable from publisher's website |
| 999 |
_c12171764 _d12171764 |
||